CLINICAL_TRIALS
trial_result
· 2023-06-28
Clinical Trial Update: Proof of Mechanism Study for the Treatment of Social Anhedonia in ASD [Phase 2]
Summary
Phase 2 proof-of-mechanism study investigating a treatment for social anhedonia in autism spectrum disorder (ASD).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of California, Los Angeles | Conditions: ASD | Phase 2 | Status: UNKNOWN